Jiangsu Hansoh Pharmaceutical Group Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CARFILZOMIB, NON-STERILE, BULK DRUG SUBSTANCE, with a corresponding US DMF Number 41263.
Remarkably, this DMF maintains an Active status since its submission on March 10, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 24, 2025, and payment made on April 08, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II